Kent-based medical chemicals manufacturer MEDICHEM is speeding up the launch and increasing production of its new nano technology-based bio-security formulation, TriGene ADVANCE, amid fears of the spread of a new and highly aggressive strain of Clostridium difficile (C.diff).
An investigation by the BBC’s Tonight programme into how NHS hospitals are dealing with the spread of C.diff revealed that some had failed to put in place adequate hygiene precautions and that many nurses were not well enough trained in infection control.
GPs have found it difficult to diagnose the new superbug when patients exhibit some of its symptoms, and often admit them to hospital for further examination. Dr Mark Enright, a microbiologist at Imperial College London, said: “Once a patient is admitted to hospital, the C.diff bacterium can spread like wildfire and everyone on the ward will have some degree of infection.”
MediChem’s Managing Director, Rick Hayman, said: “TriGene ADVANCE is a ‘first’ in hygiene science, as it uses a faster and more effective solution delivered by microemulsion technology to target areas previously inaccessible to conventional, older-generation disinfectants.”
